Arrowhead Pharmaceuticals Inc (ARWR)
18.54
+0.26
(+1.42%)
USD |
NASDAQ |
Nov 22, 16:00
18.53
-0.01
(-0.05%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Max Drawdown (5Y): 80.44% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 80.44% |
| September 30, 2024 | 78.59% |
| August 31, 2024 | 76.57% |
| July 31, 2024 | 76.57% |
| June 30, 2024 | 76.57% |
| May 31, 2024 | 76.57% |
| April 30, 2024 | 76.57% |
| March 31, 2024 | 76.57% |
| February 29, 2024 | 76.57% |
| January 31, 2024 | 76.57% |
| December 31, 2023 | 76.57% |
| November 30, 2023 | 76.57% |
| October 31, 2023 | 74.33% |
| September 30, 2023 | 73.83% |
| August 31, 2023 | 73.83% |
| July 31, 2023 | 73.83% |
| June 30, 2023 | 73.83% |
| May 31, 2023 | 73.83% |
| April 30, 2023 | 75.84% |
| March 31, 2023 | 76.03% |
| February 28, 2023 | 76.03% |
| January 31, 2023 | 80.58% |
| December 31, 2022 | 86.00% |
| November 30, 2022 | 88.18% |
| October 31, 2022 | 88.18% |
| Date | Value |
|---|---|
| September 30, 2022 | 88.18% |
| August 31, 2022 | 89.50% |
| July 31, 2022 | 93.64% |
| June 30, 2022 | 94.35% |
| May 31, 2022 | 94.35% |
| April 30, 2022 | 94.58% |
| March 31, 2022 | 94.58% |
| February 28, 2022 | 94.58% |
| January 31, 2022 | 94.58% |
| December 31, 2021 | 94.58% |
| November 30, 2021 | 95.33% |
| October 31, 2021 | 95.33% |
| September 30, 2021 | 95.33% |
| August 31, 2021 | 95.33% |
| July 31, 2021 | 95.33% |
| June 30, 2021 | 95.33% |
| May 31, 2021 | 95.33% |
| April 30, 2021 | 95.33% |
| March 31, 2021 | 95.33% |
| February 28, 2021 | 95.33% |
| January 31, 2021 | 95.33% |
| December 31, 2020 | 95.33% |
| November 30, 2020 | 95.33% |
| October 31, 2020 | 95.33% |
| September 30, 2020 | 95.33% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
73.83%
Minimum
May 2023
95.33%
Maximum
Nov 2019
87.59%
Average
94.47%
Median
Max Drawdown (5Y) Benchmarks
| Vaxcyte Inc | -- |
| CEL-SCI Corp | 96.78% |
| AIM ImmunoTech Inc | 99.76% |
| IGC Pharma Inc | 97.77% |
| NovaBay Pharmaceuticals Inc | 99.98% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -28.04 |
| Beta (5Y) | 0.9319 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 64.05% |
| Historical Sharpe Ratio (5Y) | -0.25 |
| Historical Sortino (5Y) | -0.5316 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 25.69% |